Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Menter

Showing results (1-10 of 298) with videos related to

Pageof 30
Sort By:
Journal of Drugs in Dermatology : JDD|April 22, 2004
Rationale for the use of topical corticosteroids in melasmaAlan Menter
Cutis|November 18, 2009
The status of biologic therapies in the treatment of moderate to severe psoriasisAlan Menter
Seminars in Cutaneous Medicine and Surgery|September 5, 2014
Recognizing and managing comorbidities and complications in hidradenitis suppurativaAlan Menter
Journal of the American Academy of Dermatology|December 21, 2013
Reply: To PMID 23317980Alan Menter
Journal of the American Academy of Dermatology|February 18, 2010
Goeckerman therapy versus biologics in the treatment of psoriasisAlan Menter
Dermatology and Therapy|October 24, 2023
Summary of Research: Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled TrialAlan Menter
The American Journal of Managed Care|June 30, 2016
Psoriasis and psoriatic arthritis treatmentAlan Menter
Cutis|December 25, 2007
Topical monotherapy with clobetasol propionate spray 0.05% in the COBRA trialAlan Menter
Cutis|April 6, 2012
Clobetasol propionate spray 0.05% for the treatment of moderate to severe plaque psoriasisAlan Menter
Journal of the American Academy of Dermatology|March 17, 2012
Response to the letter to editor re: "Methotrexate and psoriasis: consensus conference"Alan Menter
Pageof 30

Showing results (1-10 of 298) with videos related to

Sort By:
Pageof 30
Journal of Drugs in Dermatology : JDD|April 22, 2004
Rationale for the use of topical corticosteroids in melasmaAlan Menter
Cutis|November 18, 2009
The status of biologic therapies in the treatment of moderate to severe psoriasisAlan Menter
Seminars in Cutaneous Medicine and Surgery|September 5, 2014
Recognizing and managing comorbidities and complications in hidradenitis suppurativaAlan Menter
Journal of the American Academy of Dermatology|December 21, 2013
Reply: To PMID 23317980Alan Menter
Journal of the American Academy of Dermatology|February 18, 2010
Goeckerman therapy versus biologics in the treatment of psoriasisAlan Menter
Dermatology and Therapy|October 24, 2023
Summary of Research: Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled TrialAlan Menter
The American Journal of Managed Care|June 30, 2016
Psoriasis and psoriatic arthritis treatmentAlan Menter
Cutis|December 25, 2007
Topical monotherapy with clobetasol propionate spray 0.05% in the COBRA trialAlan Menter
Cutis|April 6, 2012
Clobetasol propionate spray 0.05% for the treatment of moderate to severe plaque psoriasisAlan Menter
Journal of the American Academy of Dermatology|March 17, 2012
Response to the letter to editor re: "Methotrexate and psoriasis: consensus conference"Alan Menter
Pageof 30